|
By Matthew Quinn
Robert Hull will leave his role as CFO of GMAC Financial Services at the end of March to take the same position at private equity firm Providence Equity Partners. He had held the top finance job at GMAC since 2007. The lender said it will conduct an internal and external search for potential CFO candidates.
Human Genome Sciences announced that David Southwell will become its chief financial officer effective March 22. He has served as a member of the HGS board of directors since July 2008. He is resigning from the board to accept this new position. Prior to joining the HGS board, he was the CFO of Sepracor, a research-based pharmaceutical company. HGS's previous CFO, Timothy Barabe, resigned earlier this month to pursue other opportunities.
MarketAxess Holdings, an electronic bond-trading platform operator, named Antonio DeLise as its new chief financial officer. He replaces James Rucker, who will be the new chief operations, credit and risk officer, the company said. Delise was previously the head of accounting and finance at MarketAxess. He joined the company in 2006 after serving as CFO for PubliCard for 11 years.
Dow Chemical named William Weideman as its chief financial officer. The 55-year-old had been interim CFO since last November when Dow's former finance chief, Geoffrey Merszei, was appointed president of the company's operations in Europe, the Middle East and Africa. Weideman has worked at Dow for more than 30 years. He was previously the company's controller.
On the hunt: The New York Post reports that Bank of America is in the market for "an ace chief financial officer" to replace Joseph Price, who was named head of consumer banking at the bank last month. Appointing a new CFO is described as a "top priority" for the bank's new CEO Brian Moynihan. Chief accounting officer Neil Cotty is currently interim CFO.
 |
in CFO Conversations by 
Subscribe to this comment's feed
